ASHP Publishes New Edition of Popular Teddy Bear Book

Published Online: Thursday, August 8, 2013

The American Society of Health-System Pharmacists (ASHP) has published the tenth edition of its popular Pediatric Injectable Drugs, widely known as the “Teddy Bear Book.”

Pediatric Injectable Drugs, Tenth Edition , edited by Stephanie J. Phelps, Pharm.D., BCPS; Tracy M. Hagemann, Pharm.D., FCCP, FPPAG; Kelley R. Lee, Pharm.D., BCPS; and A. Jill Thompson, Pharm.D., BCPS, is an invaluable resource for any pharmacist who works with children.

The Teddy Bear Book has provided reliable, evidence-based information specific to pediatric injectable drugs for more than two decades. With the publication of this new edition, the reference now covers 238 drugs commonly used in the treatment of infants and children, including 20 that are new to this edition. The reference covers neonates through adolescent children and includes age-specific dosing and administration guidelines. As with previous editions, the structure of each of the drug monographs covers the following areas:
  • Brand names,
  • Medication error potential,
  • Contraindications and warnings,
  • Infusion-related cautions,
  • Dosage (age specific),
  • Dosage adjustment in organ dysfunction,
  • Maximum dosage,
  • Additives,
  • Suitable diluents,
  • Maximum concentrations,
  • Preparation and delivery,
  • I.V. push,
  • Intermittent infusion,
  • Continuous infusion,
  • Other routes of administration, and
  • Comments.
Also included is a comprehensive list of abbreviations and more than 4,800 references. This is the only pediatric parenteral drug reference that covers limited fluid amounts, maximum doses, and limited intravenous sites—issues that pediatric practitioners often face with their patient population, from neonates through adolescents.

As a companion to the text, a mobile app is currently being developed for both single-user and institutional access. Visit for updates and additional material, information about the app, eBook, or to place an order (ISBN: 978-1-85828-379-8), or email or call 866-279-0681 (U.S. & Canada), or 001-301-664-8700 (international). 
Latest Articles
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.
The FDA has again rejected AMAG Pharmaceuticals’ application for a single-dose version of hydroxyprogesterone caproate injection (Makena) to reduce the risk of preterm birth for at-risk women.
Latest Issues